REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $171,000 | -45.0% | 339,292 | -4.9% | 0.00% | – |
| Q2 2022 | $311,000 | -65.5% | 356,675 | -0.2% | 0.00% | – |
| Q1 2022 | $901,000 | +15.8% | 357,493 | +18.6% | 0.00% | – |
| Q4 2021 | $778,000 | -45.6% | 301,315 | -3.5% | 0.00% | – |
| Q3 2021 | $1,430,000 | -27.9% | 312,139 | +8.2% | 0.00% | – |
| Q2 2021 | $1,984,000 | -23.8% | 288,363 | -18.9% | 0.00% | – |
| Q1 2021 | $2,603,000 | -3.2% | 355,606 | +6.9% | 0.00% | – |
| Q4 2020 | $2,688,000 | – | 332,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |